| Particulars |
|
|
|
| Company Name
| Balaxi Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
11.04 |
B.V. (₹) |
23.80 |
| Sales(₹ Cr.) |
60.99 |
NP (₹ Cr.) |
3.60 |
| NP Var% |
-2.00 |
Div% |
0.00 |
| CPS(₹) |
0.70 |
EPS (₹) |
0.70 |
| Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
69.00 |
| 52 Week Low |
15.00 |
Price BSE |
0.00 |
| Price NSE |
22.00 |
Market Capital (₹ Cr.) |
120.79 |
| P/C Ratio |
29.90 |
P/E Ratio |
33.70 |
| Price Vs.BV |
0.92 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
24.59 |
| NP(₹ Cr.) |
1.53 |
NP Var % |
-12.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var% |
-9.40 |
EPS |
0.69 |
| PE |
31.71 |
|
|